Clinical Trial Update: A Phase I First-in-human Trial of Bvax (B-cell Vaccination) in Addition to Standard of Care Chemoradiotherapy for Newly Diagnosed Glioblastoma [Phase 1]

View source ↗

Summary

A Phase I (first-in-human) trial evaluating Bvax, a B-cell vaccination, in addition to standard chemoradiotherapy for newly diagnosed glioblastoma; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Bvax (B-cell vaccination)

Snippet

Sponsor: Catalina Lee Chang | Conditions: Glioblastoma | Phase 1 | Status: NOT_YET_RECRUITING